glp-1 receptor agonists and sglt2 inhibitors vs. to Treat the Heart, the Kidneys the Brain Combining GLP-1 Receptor Agonists and
Description
But from 2030, Pfizer could emerge as a credible Top-3 obesity player if both the injectable and oral combo strategies succeed
Some of the dual and triple agonists have already shown initial successes in clinical trials, although the molecular mechanisms underlying their multiplexed pharmacology remain elusive
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are peptide-derived analogs that were initially investigated to treat type 2 diabetes
Here's what researchers found.
